Threw a few bucks at HEMP months ago but it's down...I'll just let it ride...PG though has been good past few months..Also bought some IGT that gained a bit...All this money earned by buying and trading BYD last year or so.They had a good run..
And I hear what Raiders22 says,my investments are basically looking for quick hits and fund longer term..Like I got a clue..
Threw a few bucks at HEMP months ago but it's down...I'll just let it ride...PG though has been good past few months..Also bought some IGT that gained a bit...All this money earned by buying and trading BYD last year or so.They had a good run..
And I hear what Raiders22 says,my investments are basically looking for quick hits and fund longer term..Like I got a clue..
I quit gambling about a year and a half ago and have been pumping all of my money into Dynavax Technologies (DVAX) since it was $1. My average is now about $1.30 ($13.00). There was a 1-10 reverse split, so it's about $17 right now.
They have a Hepatitis B vaccine that's in the final phase for approval which is scheduled to come in September of 2015. They have already done smaller trials with great success. The only reason they aren't approved already is because the sample size was too small. They worked with the FDA to determine appropriate sample size for this last trial.
Biotechs are typically high risk, high rewards which is why I was drawn to them. This is a pretty safe biotech by normal standards though. Safety has already been determined, and it's already proven to be more effective than the industry standard Hepatitis B treatment.
If you got money to park for 9 months, DVAX is a good bet. Price targets on it are $40-$60. The last time they were close to approval it was around the equivalent of $40 a share. So that's over double your money.
The stock market is long due for a correction, so these blue chips are going to get a hair cut sometime. Biotechs didn't do that great in 2014, and they typically are immune to stock market corrections.
I quit gambling about a year and a half ago and have been pumping all of my money into Dynavax Technologies (DVAX) since it was $1. My average is now about $1.30 ($13.00). There was a 1-10 reverse split, so it's about $17 right now.
They have a Hepatitis B vaccine that's in the final phase for approval which is scheduled to come in September of 2015. They have already done smaller trials with great success. The only reason they aren't approved already is because the sample size was too small. They worked with the FDA to determine appropriate sample size for this last trial.
Biotechs are typically high risk, high rewards which is why I was drawn to them. This is a pretty safe biotech by normal standards though. Safety has already been determined, and it's already proven to be more effective than the industry standard Hepatitis B treatment.
If you got money to park for 9 months, DVAX is a good bet. Price targets on it are $40-$60. The last time they were close to approval it was around the equivalent of $40 a share. So that's over double your money.
The stock market is long due for a correction, so these blue chips are going to get a hair cut sometime. Biotechs didn't do that great in 2014, and they typically are immune to stock market corrections.
slamspurs,
"I quit gambling about a year and a half ago and have been pumping all of my money into Dynavax Technologies (DVAX) since it was $1. My average is now about $1.30 ($13.00). There was a 1-10 reverse split, so it's about $17 right now.
They have a Hepatitis B vaccine that's in the final phase for approval which is scheduled to come in September of 2015. They have already done smaller trials with great success. The only reason they aren't approved already is because the sample size was too small. They worked with the FDA to determine appropriate sample size for this last trial.
Biotechs are typically high risk, high rewards which is why I was drawn to them."
So did you really quit gambling?
slamspurs,
"I quit gambling about a year and a half ago and have been pumping all of my money into Dynavax Technologies (DVAX) since it was $1. My average is now about $1.30 ($13.00). There was a 1-10 reverse split, so it's about $17 right now.
They have a Hepatitis B vaccine that's in the final phase for approval which is scheduled to come in September of 2015. They have already done smaller trials with great success. The only reason they aren't approved already is because the sample size was too small. They worked with the FDA to determine appropriate sample size for this last trial.
Biotechs are typically high risk, high rewards which is why I was drawn to them."
So did you really quit gambling?
slamspurs,
"I quit gambling about a year and a half ago and have been pumping all of my money into Dynavax Technologies (DVAX) since it was $1. My average is now about $1.30 ($13.00). There was a 1-10 reverse split, so it's about $17 right now.
They have a Hepatitis B vaccine that's in the final phase for approval which is scheduled to come in September of 2015. They have already done smaller trials with great success. The only reason they aren't approved already is because the sample size was too small. They worked with the FDA to determine appropriate sample size for this last trial.
Biotechs are typically high risk, high rewards which is why I was drawn to them."
So did you really quit gambling?
People have different ways of coping with addiction. To me, the stock is relatively safe, but in a higher risk sector.
Would you consider it gambling if I invested in a company like Merck, Phizer, or Johnson and Johnson.
Or are you just saying that the stock market is gambling just like sports betting is?
slamspurs,
"I quit gambling about a year and a half ago and have been pumping all of my money into Dynavax Technologies (DVAX) since it was $1. My average is now about $1.30 ($13.00). There was a 1-10 reverse split, so it's about $17 right now.
They have a Hepatitis B vaccine that's in the final phase for approval which is scheduled to come in September of 2015. They have already done smaller trials with great success. The only reason they aren't approved already is because the sample size was too small. They worked with the FDA to determine appropriate sample size for this last trial.
Biotechs are typically high risk, high rewards which is why I was drawn to them."
So did you really quit gambling?
People have different ways of coping with addiction. To me, the stock is relatively safe, but in a higher risk sector.
Would you consider it gambling if I invested in a company like Merck, Phizer, or Johnson and Johnson.
Or are you just saying that the stock market is gambling just like sports betting is?
If you choose to make use of any information on this website including online sports betting services from any websites that may be featured on this website, we strongly recommend that you carefully check your local laws before doing so. It is your sole responsibility to understand your local laws and observe them strictly. Covers does not provide any advice or guidance as to the legality of online sports betting or other online gambling activities within your jurisdiction and you are responsible for complying with laws that are applicable to you in your relevant locality. Covers disclaims all liability associated with your use of this website and use of any information contained on it. As a condition of using this website, you agree to hold the owner of this website harmless from any claims arising from your use of any services on any third party website that may be featured by Covers.